From NE Now
Center Owned by NE NowAssam: 137 anti-cancer medicines to be sold at revised lower prices from November 9
What's behind this
From 9 November, the National Pharmaceutical Pricing Authority (NPPA) reduced the maximum retail price of 543 anti‑cancer medicines, aiming to make cancer treatment more affordable and estimating patient savings of ₹2,500‑3,500 crore annually. In Assam, the Drugs Control Administration ordered all retailers, distributors, stockists and hospitals to sell 137 non‑scheduled anti‑cancer medicines at the revised lower MRP from the same date.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
center · 1 outlet
Guwahati: The Assam Drugs Control Administration has directed all retailers, distributors, stockists and hospitals across the state to sell 137 non-scheduled anti-cancer medicines at revised, reduced maximum retail prices (MRP) from November 9. In a notice issued on Monday, the administration warned…
— NE Now
-
right · 1 outlet
NPPA slashed maximum retail prices for 543 anti-cancer medicines from 9 November, with aim to make cancer treatment more affordable. It estimates the cuts could save patients ₹2,500–3,500 crore in annual out-of-pocket spending.
— Livemint
RSS excerpt
Guwahati: The Assam Drugs Control Administration has directed all retailers, distributors, stockists and hospitals across the state to sell 137 non-scheduled anti-cancer medicines at revised, reduced maximum retail prices (MRP) from November 9. In a notice issued on Monday, the administration warned…
